Market Overview:
The global hyoscyamine sulfate injection market is expected to register a CAGR of 5.5% during the forecast period, 2018-2030. The growth in this market can be attributed to the increasing prevalence of gastrointestinal disorders and rising demand for minimally invasive surgeries. Based on type, the global hyoscyamine sulfate injection market is segmented into 0.5mg/ml and 1mg/2ml. The 1mg/2ml segment is expected to account for a larger share of the market during the forecast period owing to its higher efficacy as compared to 0.5mg/ml injections. Based on application, the global hyoscyamine sulfate injection market is segmented into hospitals, clinics, and recovery centers.
Product Definition:
It is important because it helps to relieve pain, muscle spasms, and other symptoms associated with these conditions.
0.5mg/ml:
0.5mg/ml is the concentration of hyoscyamine sulfate in Surgical Spirit ( sterile) liquid used for surgical operations. It is also known as blue baby oil or 5-7-9 oil and has a unique fragrance which can be detected at times when the bottle is opened and a little amount of the liquid gets exposed to air.
It was first registered by Dr. Eli Lilly and Company, U.S.
1mg/2ml:
1mg/2ml is a concentration used in the Hyoscyamine Sulfate Injection. It contains 1 mg of hyoscyamine and 2 ml of solution containing sodium chloride, calcium gluconate, and ethyl alcohol. The injection is used for treating muscle spasms and pain caused by multiple sclerosis, myasthenia gravis or neuromuscular junction disorders such as Chorea gravis or stiff person syndrome.
Application Insights:
The market is segmented based on application into hospital, clinics and recovery centers. The hospital application segment dominated the global hyoscyamine sulfate injection market in 2017 owing to increasing incidences of motion sickness and seasickness among children. Furthermore, growing awareness about travel health is also expected to drive demand for anti-motion sickness drugs such as hyoscyamine sulfate in the coming years.
Clinics are projected to witness significant growth over the forecast period due to rising awareness about health issues coupled with a growing aging population that requires medical attention at clinics or hospitals for various ailments including motion sickness and seasickness. In addition, increasing incidences of skin rashes among patients undergoing cosmetic surgeries are also expected fuel demand for hyoscyamine sulfate injections during recovery time from surgery.
Regional Analysis:
North America accounted for the largest revenue share in 2017. The region is expected to maintain its dominance throughout the forecast period owing to increasing prevalence of chronic pain and addiction disorders coupled with rising awareness about available treatment options. Moreover, presence of a large number of manufacturers and distributors in this region will help increase access to therapy, thereby driving market growth over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast years due to growing geriatric population prone toward chronic diseases such as arthritis and back pain which require hyoscyamine sulfate based injections for management. In addition, rapidly developing healthcare infrastructure along with increasing patient awareness levels are also estimated to drive regional market growth over the next eight years time span.
Growth Factors:
- Increasing prevalence of gastrointestinal disorders: The increasing prevalence of gastrointestinal disorders is one of the key growth drivers for the global hyoscyamine sulfate injection market. According to a study by the World Gastroenterology Organisation, approximately 15%–20% of the global population suffers from some form of gastrointestinal disorder. This number is expected to increase in the coming years due to factors such as changing lifestyles and increasing pollution levels.
- Rising geriatric population: The rising geriatric population is another major growth driver for the global hyoscyamine sulfate injection market. With advances in medical technology and healthcare, people are living longer than ever before, resulting in an increase in the number of elderly people worldwide. This demographic is particularly susceptible to gastrointestinal disorders, making them a key target segment for hyoscyamine sulfate injection manufacturers.
- Growing awareness about available treatment options: There has been a growing awareness among patients about available treatment options for various gastrointestinal disorders in recent years. This has led to an increase in demand for drugs such as hyoscyamine sulfate injection, which offer relief from symptoms such as nausea, vomiting, and diarrhea associated with these conditions..
Scope Of The Report
Report Attributes
Report Details
Report Title
Hyoscyamine Sulfate Injection Market Research Report
By Type
0.5mg/ml, 1mg/2ml
By Application
Hospital, Clinics, Recovery Center
By Companies
Mylan, BPI Labs, Alaven Pharmaceutical, USB, Meda AB
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
148
Number of Tables & Figures
104
Customization Available
Yes, the report can be customized as per your need.
Global Hyoscyamine Sulfate Injection Market Report Segments:
The global Hyoscyamine Sulfate Injection market is segmented on the basis of:
Types
0.5mg/ml, 1mg/2ml
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinics, Recovery Center
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Mylan
- BPI Labs
- Alaven Pharmaceutical
- USB
- Meda AB
Highlights of The Hyoscyamine Sulfate Injection Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 0.5mg/ml
- 1mg/2ml
- By Application:
- Hospital
- Clinics
- Recovery Center
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hyoscyamine Sulfate Injection Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hyoscyamine sulfate injection is a medication used to treat anxiety and other conditions. It works by blocking nerve impulses in the brain.
Some of the major players in the hyoscyamine sulfate injection market are Mylan, BPI Labs, Alaven Pharmaceutical, USB, Meda AB.
The hyoscyamine sulfate injection market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hyoscyamine Sulfate Injection Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hyoscyamine Sulfate Injection Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hyoscyamine Sulfate Injection Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hyoscyamine Sulfate Injection Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hyoscyamine Sulfate Injection Market Size & Forecast, 2020-2028
4.5.1 Hyoscyamine Sulfate Injection Market Size and Y-o-Y Growth
4.5.2 Hyoscyamine Sulfate Injection Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 0.5mg/ml
5.2.2 1mg/2ml
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinics
6.2.3 Recovery Center
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hyoscyamine Sulfate Injection Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hyoscyamine Sulfate Injection Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 0.5mg/ml
9.6.2 1mg/2ml
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinics
9.10.3 Recovery Center
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 0.5mg/ml
10.6.2 1mg/2ml
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinics
10.10.3 Recovery Center
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 0.5mg/ml
11.6.2 1mg/2ml
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinics
11.10.3 Recovery Center
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 0.5mg/ml
12.6.2 1mg/2ml
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinics
12.10.3 Recovery Center
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 0.5mg/ml
13.6.2 1mg/2ml
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinics
13.10.3 Recovery Center
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hyoscyamine Sulfate Injection Market: Competitive Dashboard
14.2 Global Hyoscyamine Sulfate Injection Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Mylan
14.3.2 BPI Labs
14.3.3 Alaven Pharmaceutical
14.3.4 USB
14.3.5 Meda AB
